COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,367 Articles (22,803 medRxiv, 8,564 bioRxiv)

Most recent first Previous |  Page 684: Articles 6831-6840  | Next

Adjusted booster schedules disperse age-dependent differences in antibody titers benefitting risk populations - Update to: Age-dependent Immune Response to the BioNTech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination
Müller, L., Andree, M., Moskorz, W., Drexler, I., Hauka, S., Ptok, J., Walotka, L., Grothmann, R., Hillebrandt, J., Ritchie, A., Peter, L., Walker, A., Timm, J., Adams, O., Schaal, H.
10.1101/2022.08.08.22278545 — Posted: 2022-08-09
Spike-specific CXCR3+ TFH cells play a dominant functional role in supporting antibody responses in SARS-CoV-2 infection and vaccination
Zhang, J., He, R., Liu, B., Zheng, X., Wu, Q., Wen, B., Wang, Q., Liu, Z., Chang, F., Hu, Y., Xie, T., Liu, Y., Chen, J., Yang, J., Teng, S., Bai, T., Peng, Y., Liu, Z., Peng, Y., Huang, W. J., Terzieva, V., Wang, Y., Liu, W., Li, Y.-P., Qu, X.
10.1101/2022.08.09.503302 — Posted: 2022-08-09
Cyclical Student Shifting Models in a Limited Face-to-Face Learning Modality in the time of COVID-19 Pandemic in the Philippines
Balsomo, A. J., Sabinay, S. G.
10.1101/2022.08.09.22278587 — Posted: 2022-08-09
Inequalities in colorectal cancer screening uptake in Wales: examination of the impact of the temporary suspension of the screening programme during the COVID-19 pandemic
Bright, D., Hillier, S., Song, J., Huws, D. W., Greene, G., Hodgson, K., Akbari, A., Griffiths, R., Davies, A. R.
10.1101/2022.08.08.22278493 — Posted: 2022-08-09
Understanding the impact of COVID-19 risk perceptions on mitigation behaviors: A mixed methods approach using survey instruments and serious games
Merrill, S. C., Nowak, S. A., Shrum, T. R., Hanley, J. P., Clark, E. M., Fredrickson, L., Liu, T.-L., Beattie, R. M., OKeefe, A., Zia, A., Koliba, C. J.
10.1101/2022.08.07.22278512 — Posted: 2022-08-09
Estimating COVID-19 Vaccine Efficacy via Dynamic Epidemiological Models--A Study of Ten Countries
Zhu, Y., Gu, J., Qiu, Y., Chen, S.
10.1101/2022.08.08.22278571 — Posted: 2022-08-09
Quantifying the impact of delaying the second COVID-19 vaccine dose in England: a mathematical modelling study
Imai, N., Rawson, T., Knock, E. S., Sonabend, R., Elmaci, Y., Perez-Guzman, P. N., Whittles, L. K., Thekke Kanapram, D., Gaythorpe, K. A., Hinsley, W., Djaafara, B. A., Wang, H., Fraser, K., FitzJohn, R. G., Hogan, A. B., Doohan, P., Ghani, A. C., Ferguson, N. M., Baguelin, M., Cori, A.
10.1101/2022.08.08.22278528 — Posted: 2022-08-09
Metabolomic and gut microbiome profiles across the spectrum of community-based COVID and non-COVID disease: A COVID-19 Biobank study.
Österdahl, M. F., Whiston, R., Sudre, C. H., Asnicar, F., Cheetham, N. J., Blanco Miguez, A., Bowyer, V., Antonelli, M., Snell, O., dos Santos Canas, L., Hu, C., Wolf, J., Menni, C., Malim, M., Hart, D., Spector, T., Berry, S., Segata, N., Doores, K., Ourselin, S., Duncan, E. L., Steves, C. J.
10.1101/2022.08.07.22278510 — Posted: 2022-08-09
The prognostic value of transthoracic echocardiography findings in hospitalized adult patients with COVID-19: A single-center retrospective analysis
Muliawan, H. S., Agarwal, R., Nugraha, R. A., Priyonugroho, G., Hertine, S., Wicaksono, S. H., Almazini, P., Zamroni, D.
10.1101/2022.08.07.22278506 — Posted: 2022-08-09
Clinical effectiveness of SARS-CoV-2 booster vaccine against Omicron infection in residents and staff of Long-Term Care Facilities: a prospective cohort study (VIVALDI)
Stirrup, O., Shrotri, M., Adams, N. L., Krutikov, M., Nacer-Laidi, H., Azmi, B., Palmer, T., Fuller, C., Irwin-Singer, A., Baynton, V., Tut, G., Moss, P., Hayward, A., Copas, A., Shallcross, L.
10.1101/2022.08.08.22278532 — Posted: 2022-08-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).